Concepedia

Shelley Orwick

SO

Statistics

Publications

43

Citations

2.5K

H-Index

31

Active since

2008

Affiliations

The Ohio State University(Current)

University of Alabama at Birmingham

St. Jude Children's Research Hospital

Hofstra University

Dana-Farber Cancer Institute

Shelley Orwick is an author at The Ohio State University specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2008–2024

43

Publications

43

Interaction of Imatinib with Human Organic Ion Carriers

Shuiying Hu, Ryan M. Franke, Kelly K. Filipski et al. · Clinical Cancer Research · 2008 · 232 citations · Full text

, , +17

Crenolanib is active against models of drug-resistant FLT3-ITD−positive acute myeloid leukemia

Eric I. Zimmerman, David C. Turner, Jassada Buaboonnam et al. · Blood · 2013 · 183 citations · Full text

, , +8

Contribution of OATP1B1 and OATP1B3 to the Disposition of Sorafenib and Sorafenib-Glucuronide

Eric I. Zimmerman, Shuiying Hu, Justin L. Roberts et al. · Clinical Cancer Research · 2013 · 161 citations · Full text

, , +17

Interaction of the Multikinase Inhibitors Sorafenib and Sunitinib with Solute Carriers and ATP-Binding Cassette Transporters

Shuiying Hu, Zhaoyuan Chen, Ryan M. Franke et al. · Clinical Cancer Research · 2009 · 159 citations · Full text

, , +17

Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/ <i>KMT2A</i>

Marius Bill, Krzysztof Mrózek, Jessica Kohlschmidt et al. · Proceedings of the National Academy of Sciences · 2020 · 102 citations · Full text

, , +17

1–5 of 43